$214.34 1.4%
LH Stock Price vs. AI Score
Data gathered: July 23

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About LabCorp

Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries.


LabCorp
Price $214.34
Target Price Sign up
Volume 594,070
Market Cap $17.9B
Year Range $192.5 - $230.95
Dividend Yield 1.36%
PE Ratio 45.55
Earnings Date August 1 '24
Industry Health Care Services

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '243.18B2.28B897M228M404M3.680
Q4 '233.03B2.21B821M-167M-32M3.300
Q3 '233.06B2.21B851M183M344M3.380
Q2 '233.03B2.19B842M189M340M3.800
Q1 '233.04B2.19B850M213M406M3.820

Insider Transactions View All

Van Der Vaart Sandra D filed to sell 5,637 shares at $210.8.
May 16 '24
Van Der Vaart Sandra D filed to sell 5,837 shares at $210.8.
May 16 '24
ANDERSON KERRII B filed to sell 15,722 shares at $200.1.
May 2 '24
Wilkinson Peter J filed to sell 2,087 shares at $204.3.
May 1 '24
Summy Amy B. filed to sell 3,975 shares at $217.3.
April 3 '24

What is the Market Cap of LabCorp?

The Market Cap of LabCorp is $17.9B.

What is LabCorp's PE Ratio?

As of today, LabCorp's PE (Price to Earnings) ratio is 45.55.

When does LabCorp report earnings?

LabCorp will report its next earnings on August 1 '24.

What is the current stock price of LabCorp?

Currently, the price of one share of LabCorp stock is $214.34.

How can I analyze the LH stock price chart for investment decisions?

The LH stock price chart above provides a comprehensive visual representation of LabCorp's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling LabCorp shares. Our platform offers an up-to-date LH stock price chart, along with technical data analysis and alternative data insights.

Does LH offer dividends to its shareholders?

Yes, LabCorp (LH) offers dividends to its shareholders, with a dividend yield of 1.36%. This dividend yield represents LabCorp's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering LabCorp in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of LabCorp?

Some of the similar stocks of LabCorp are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.